Cassava Sciences | PTIE - Trade Creditors


Cassava Sciences reported $41.65M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
Cara Therapeutics USD 4.08M 1.65M Sep/2025
Cassava Sciences USD 41.65M 4.44M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Geron USD 11.26M 146K Dec/2025
J&J USD 10.46B 1.53B Mar/2026
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.46B 99M Dec/2025
Novavax USD 24.58M 9.35M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025